Design and nuclear magnetic resonance (NMR) structure determination of the second extracellular immunoglobulin tyrosine kinase A (TrkAIg2) domain construct for binding site elucidation in drug discovery. (2015)
Attributed to:
Core Capability for Chemistry Research - Strategic Investment in Mass Spectrometry
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/jm501307e
PubMed Identifier: 25454499
Publication URI: http://europepmc.org/abstract/MED/25454499
Type: Journal Article/Review
Volume: 58
Parent Publication: Journal of medicinal chemistry
Issue: 2
ISSN: 0022-2623